Ovintiv Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Ovintiv Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.91B | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $9.15B | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | $10.88B | Feb 23, 2026 |
| FY2024 | Dec 31, 2022 | $12.46B | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $8.66B | Feb 27, 2024 |
| FY2020 | Dec 31, 2020 | $1.53B | Feb 18, 2021 |
| FY2020 | Sep 30, 2020 | $1.19B | Feb 18, 2021 |
| FY2020 | Jun 30, 2020 | $726.00M | Feb 18, 2021 |
| FY2020 | Mar 31, 2020 | $2.64B | Feb 18, 2021 |
| FY2020 | Dec 31, 2019 | $1.57B | Feb 18, 2021 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.66B | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $8.94B | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | $10.66B | Feb 23, 2026 |
| FY2024 | Dec 31, 2022 | $14.26B | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $10.47B | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $5.51B | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $7.01B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $5.46B | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $3.89B | Feb 21, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.24B | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $1.13B | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | $2.09B | Feb 23, 2026 |
| FY2024 | Dec 31, 2022 | $3.64B | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $1.42B | Feb 27, 2024 |
| FY2020 | Dec 31, 2020 | ($614.00M) | Feb 18, 2021 |
| FY2020 | Sep 30, 2020 | ($1.52B) | Feb 18, 2021 |
| FY2020 | Jun 30, 2020 | ($4.38B) | Feb 18, 2021 |
| FY2020 | Mar 31, 2020 | $421.00M | Feb 18, 2021 |
| FY2020 | Dec 31, 2019 | ($6.00M) | Feb 18, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.13B | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $1.58B | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | $2.86B | Feb 23, 2026 |
| FY2024 | Dec 31, 2022 | $3.85B | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $1.52B | Feb 27, 2024 |
| FY2020 | Dec 31, 2020 | ($591.00M) | Feb 18, 2021 |
| FY2020 | Sep 30, 2020 | ($1.51B) | Feb 18, 2021 |
| FY2020 | Jun 30, 2020 | ($4.06B) | Feb 18, 2021 |
| FY2020 | Mar 31, 2020 | $759.00M | Feb 18, 2021 |
| FY2020 | Dec 31, 2019 | ($28.00M) | Feb 18, 2021 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.39B | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $19.25B | Feb 23, 2026 |
| FY2024 | Dec 31, 2023 | $19.99B | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $15.06B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $14.06B | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $14.47B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $21.49B | Feb 18, 2021 |
| FY2019 | Jan 1, 2019 | $15.20B | Feb 21, 2020 |
| FY2019 | Dec 31, 2018 | $15.34B | Feb 21, 2020 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.20B | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $8.92B | Feb 23, 2026 |
| FY2024 | Dec 31, 2023 | $9.62B | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $7.37B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $8.98B | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $10.63B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $11.56B | Feb 18, 2021 |
| FY2019 | Jan 1, 2019 | $7.68B | Feb 21, 2020 |
| FY2019 | Dec 31, 2018 | $7.90B | Feb 21, 2020 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.20B | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $10.33B | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | $10.37B | Feb 23, 2026 |
| FY2025 | Dec 31, 2022 | $7.69B | Feb 23, 2026 |
| FY2024 | Dec 31, 2021 | $5.07B | Feb 26, 2025 |
| FY2023 | Dec 31, 2020 | $3.84B | Feb 27, 2024 |
| FY2022 | Dec 31, 2019 | $9.93B | Feb 27, 2023 |
| FY2019 | Jan 1, 2019 | $7.52B | Feb 21, 2020 |
| FY2021 | Dec 31, 2018 | $7.45B | Feb 25, 2022 |
| FY2020 | Dec 31, 2017 | $6.73B | Feb 18, 2021 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4 | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | 4 | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | 8 | Feb 23, 2026 |
| FY2024 | Dec 31, 2022 | 14 | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | 5 | Feb 27, 2024 |
| FY2020 | Dec 31, 2020 | (2) | Feb 18, 2021 |
| FY2020 | Sep 30, 2020 | (5) | Feb 18, 2021 |
| FY2020 | Jun 30, 2020 | (16) | Feb 18, 2021 |
| FY2020 | Mar 31, 2020 | 1 | Feb 18, 2021 |
| FY2021 | Dec 31, 2019 | 0 | Feb 25, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4 | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | 4 | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | 7 | Feb 23, 2026 |
| FY2024 | Dec 31, 2022 | 14 | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | 5 | Feb 27, 2024 |
| FY2020 | Dec 31, 2020 | (2) | Feb 18, 2021 |
| FY2020 | Sep 30, 2020 | (5) | Feb 18, 2021 |
| FY2020 | Jun 30, 2020 | (16) | Feb 18, 2021 |
| FY2020 | Mar 31, 2020 | 1 | Feb 18, 2021 |
| FY2021 | Dec 31, 2019 | 0 | Feb 25, 2022 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $35.00M | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $42.00M | Feb 23, 2026 |
| FY2024 | Dec 31, 2023 | $3.00M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $5.00M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $195.00M | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $10.00M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $190.00M | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $1.06B | Feb 21, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.20B | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $5.45B | Feb 23, 2026 |
| FY2024 | Dec 31, 2023 | $5.74B | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $3.57B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $4.79B | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $6.89B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $6.97B | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $4.20B | Feb 21, 2020 |